Published in Cogn Neuropsychiatry on October 12, 2011
The somatic marker theory in the context of addiction: contributions to understanding development and maintenance. Psychol Res Behav Manag (2015) 0.97
Think twice: Impulsivity and decision making in obsessive-compulsive disorder. J Behav Addict (2015) 0.87
Trait Anxiety Has Effect on Decision Making under Ambiguity but Not Decision Making under Risk. PLoS One (2015) 0.77
Trait-related decision making impairment in obsessive-compulsive disorder: evidence from decision making under ambiguity but not decision making under risk. Sci Rep (2015) 0.75
Patients with chronic pain lack somatic markers during decision-making. J Pain Res (2014) 0.75
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
Frontal lobe dysfunction in pathological gambling patients. Biol Psychiatry (2002) 1.65
Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum Mol Genet (2004) 1.20
Understanding obsessive-compulsive disorder: focus on decision making. Neuropsychol Rev (2006) 1.14
Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. Eur J Hum Genet (2005) 1.13
Executive dysfunctions in obsessive-compulsive patients and unaffected relatives: searching for a new intermediate phenotype. Biol Psychiatry (2010) 1.11
Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study. Biol Psychiatry (2003) 1.09
Neuropsychological investigation of decision-making in anorexia nervosa. Psychiatry Res (2004) 1.08
In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. Neuroimage (2008) 1.08
Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Eur Neuropsychopharmacol (2005) 1.07
Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet (2002) 1.07
Health-related quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Clin Psychiatry (2007) 0.97
Obsessive compulsive disorder among idiopathic focal dystonia patients: an epidemiological and family study. Biol Psychiatry (2002) 0.95
Clonazepam in the treatment of psychiatric disorders: an update. Int Clin Psychopharmacol (2006) 0.95
Approximate entropy of respiratory patterns in panic disorder. Am J Psychiatry (2004) 0.94
Treatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors D2 partial agonist aripiprazole. Recent Pat Endocr Metab Immune Drug Discov (2014) 0.94
Panic disorder and control of breathing. Respir Physiol Neurobiol (2008) 0.93
The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice. Int J Mol Sci (2013) 0.92
Present and lifetime comorbidity of tobacco, alcohol and drug use in eating disorders: a European multicenter study. Drug Alcohol Depend (2008) 0.91
Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry (2014) 0.90
Panic disorder respiratory subtype: psychopathology, laboratory challenge tests, and response to treatment. Harv Rev Psychiatry (2010) 0.89
Self-injurious behavior and attempted suicide in purging bulimia nervosa: associations with psychiatric comorbidity. J Affect Disord (2007) 0.89
Executive functioning in anorexia nervosa patients and their unaffected relatives. Psychiatry Res (2012) 0.88
Low social interactions in eating disorder patients in childhood and adulthood: a multi-centre European case control study. J Health Psychol (2012) 0.88
Fat mass and obesity-associated gene (FTO) in eating disorders: evidence for association of the rs9939609 obesity risk allele with bulimia nervosa and anorexia nervosa. Obes Facts (2012) 0.87
Freezing reaction in panic disorder patients associated with anticipatory anxiety. Depress Anxiety (2009) 0.87
Use of the hospital anxiety and depression scale (HADS) in a cardiac emergency room: chest pain unit. Clinics (Sao Paulo) (2009) 0.87
Investigation of the serotonin transporter regulatory region polymorphism in bulimia nervosa: relationships to harm avoidance, nutritional parameters, and psychiatric comorbidity. Psychosom Med (2006) 0.87
Neurosteroid secretion in panic disorder. Psychiatry Res (2003) 0.87
Smoking and respiratory irregularity in panic disorder. Biol Psychiatry (2004) 0.87
A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam. Psychiatry Res (2005) 0.86
Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome. J Clin Psychopharmacol (2002) 0.86
Decision-making functioning as a predictor of treatment outcome in anorexia nervosa. Psychiatry Res (2006) 0.86
A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine. J Clin Psychopharmacol (2012) 0.85
Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. Neuropsychopharmacology (2005) 0.85
Motor inhibition and cognitive flexibility in eating disorder subtypes. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.85
Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients. Neuropsychopharmacology (2006) 0.84
Caffeine challenge test in panic disorder and depression with panic attacks. Compr Psychiatry (2007) 0.84
Panic disorder and social anxiety disorder subtypes in a caffeine challenge test. Psychiatry Res (2009) 0.84
Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. Int Clin Psychopharmacol (2009) 0.83
Artificial neural network model for the prediction of obsessive-compulsive disorder treatment response. J Clin Psychopharmacol (2009) 0.82
Virtual reality as a mechanism for exposure therapy. World J Biol Psychiatry (2010) 0.82
Novel antidepressants and panic disorder: evidence beyond current guidelines. Neuropsychobiology (2010) 0.81
Anticipation of age at onset of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder. Psychiatry Res (2002) 0.81
Demographic and clinical features of schizoaffective (schizobipolar) disorder--a 5-year retrospective study. Support for a bipolar spectrum disorder. J Affect Disord (2005) 0.81
Efficacy and safety of long acting injectable atypical antipsychotics: a review. Curr Clin Pharmacol (2013) 0.81
Respiration in children at risk for panic disorder. Arch Gen Psychiatry (2002) 0.81
Cardiorespiratory response to physical exercise and psychological variables in panic disorder. Rev Bras Psiquiatr (2011) 0.80
Case-control and combined family trios analysis of three polymorphisms in the ghrelin gene in European patients with anorexia and bulimia nervosa. Psychiatr Genet (2006) 0.80
A caffeine challenge test in panic disorder patients, their healthy first-degree relatives, and healthy controls. Depress Anxiety (2008) 0.80
Tapering clonazepam in patients with panic disorder after at least 3 years of treatment. J Clin Psychopharmacol (2010) 0.79
Effects of cigarette smoking on neuropsychological performance in mood disorders: a comparison between smoking and nonsmoking inpatients. J Clin Psychiatry (2013) 0.79
The relationship between the severity of asthma and comorbidities with anxiety and depressive disorders. Rev Bras Psiquiatr (2006) 0.78
Alpha absolute power measurement in panic disorder with agoraphobia patients. J Affect Disord (2013) 0.78
The Relationships between Cholesterol and Suicide: An Update. ISRN Psychiatry (2012) 0.78
S-Adenosyl-L-Methionine augmentation in patients with stage II treatment-resistant major depressive disorder: an open label, fixed dose, single-blind study. ScientificWorldJournal (2013) 0.78
Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study. J Clin Psychopharmacol (2004) 0.78
No association between obsessive-compulsive disorder and the 5-HT(1Dbeta) receptor gene. Am J Psychiatry (2002) 0.78
Do social anxiety disorder patients belong to a bipolar spectrum subgroup? J Affect Disord (2005) 0.78
Baseline respiratory parameters in panic disorder: a meta-analysis. J Affect Disord (2012) 0.78
Serotonergic modulation of the balance system in panic disorder: an open study. Depress Anxiety (2003) 0.77
Are respiratory abnormalities specific for panic disorder? A meta-analysis. Neuropsychobiology (2014) 0.77
Anxiety sensitivity and 35% CO2 reactivity in patients with panic disorder. J Psychosom Res (2003) 0.77
Comparison between hyperventilation and breath-holding in panic disorder: patients responsive and non-responsive to both tests. Psychiatry Res (2006) 0.77
The advantages of choosing antiobsessive therapy according to decision-making functioning. J Clin Psychopharmacol (2004) 0.77
Psychopathological profile of 35% CO2 challenge test-induced panic attacks: a comparison with spontaneous panic attacks. Compr Psychiatry (2006) 0.77
Anxiety sensitivity and modulation of the serotonergic system in patients with PD. J Anxiety Disord (2004) 0.77
Current pharmacological interventions in panic disorder. CNS Neurol Disord Drug Targets (2014) 0.76
Clonazepam for the treatment of panic disorder. Curr Drug Targets (2013) 0.76
Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature. Expert Opin Pharmacother (2010) 0.76
Randomized, open naturalistic, acute treatment of panic disorder with clonazepam or paroxetine. J Clin Psychopharmacol (2011) 0.76
Is there a hypersensitive visual alarm system in panic disorder? Psychiatry Res (2010) 0.76
Lack of relationship between CO2 reactivity and serotonin transporter gene regulatory region polymorphism in panic disorder. Am J Med Genet B Neuropsychiatr Genet (2004) 0.76
Supporting tools in psychiatric treatment decision-making: sertraline outcome investigation with artificial neural network method. Psychiatry Res (2005) 0.76
Agomelatine in Panic Disorder: A 6-Week Follow-Up Case Series. J Clin Psychopharmacol (2016) 0.76
Selective serotonin re-uptake inhibitors beyond psychiatry: are they useful in the treatment of severe, chronic, obstructive pulmonary disease? Depress Anxiety (2004) 0.76
Comparison of 35% carbon dioxide reactivity between panic disorder and eating disorder. Psychiatry Res (2004) 0.76
Caffeine and 35% carbon dioxide challenge tests in panic disorder. Hum Psychopharmacol (2007) 0.76
Double-blind comparison of 30 and 60 mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder. Psychiatry Res (2009) 0.76
Panic and the brainstem: clues from neuroimaging studies. CNS Neurol Disord Drug Targets (2014) 0.76
Novel 5'-regulatory region polymorphisms of the 5-HT2C receptor gene: association study with panic disorder. Int J Neuropsychopharmacol (2000) 0.76
Acoustic startle response in panic disorder. Psychiatry Res (2010) 0.76
Alexithymia, Suicide Ideation, C-Reactive Protein, and Serum Lipid Levels Among Outpatients with Generalized Anxiety Disorder. Arch Suicide Res (2015) 0.76